Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Recruiting 5Not yet recruiting 3Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 1217Neoplasms 1027Carcinoma, Non-Small-Cell Lung 749Prostatic Neoplasms 688Colorectal Neoplasms 593Lung Neoplasms 573Pancreatic Neoplasms 394Leukemia, Myeloid, Acute 394Neoplasm Metastasis 388Ovarian Neoplasms 370Multiple Myeloma 369Stomach Neoplasms 316Carcinoma, Hepatocellular 301Melanoma 281Brain Neoplasms 277Recurrence 273Squamous Cell Carcinoma of Head and Neck 269Head and Neck Neoplasms 237Endometrial Neoplasms 234Glioblastoma 233Triple Negative Breast Neoplasms 228Uterine Cervical Neoplasms 221Precursor Cell Lymphoblastic Leukemia-Lymphoma 221Lymphoma 221Sarcoma 201Hematologic Neoplasms 199Urinary Bladder Neoplasms 196Esophageal Neoplasms 190Carcinoma, Renal Cell 188Lymphoma, Non-Hodgkin 176

Interventions

Capecitabine 4Oxaliplatin 3camrelizumab 2toripalimab 1Radiotherapy, Intensity-Modulated 1Leucovorin 1Irinotecan 1Immune Checkpoint Inhibitors 1Fluorouracil 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Locally Advanced Rectal Cancer × 1 year × Clear all
NCT07527026 2026-04-14

A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer

Chinese PLA General Hospital

Phase 2 Recruiting
44 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT06281405 2026-04-03

TORCH-iTNT

Fudan University

Phase 2 Recruiting
192 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT05412082 2026-02-06

SMART TNT

University of Miami

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT07150949 2025-09-02

Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)

Fudan University

Phase 2 Recruiting
138 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT07057089 2025-08-14

Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer (Neo-Field I)

Hebei Medical University Fourth Hospital

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡